Biosimilars in the EU: a new guide for health professionals

With the number of biosimilar drugs being approved in the EU rising rapidly, the European Medicines Agency and the European Commission have jointly published a guide for healthcare professionals to provide reassurance on their safety and efficacy – but does it fall short of the rigorous analysis clinicians require?

Source: Prescriber - October 23, 2017 Category: Primary Care Authors: Steve Chaplin Tags: Analysis Source Type: research